Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle
- 1 August 2016
- journal article
- Published by Springer Nature in Pharmacological Reports
- Vol. 68 (4) , 692-702
Abstract
Arterial high blood pressure is a risk factor for target organ damage; the most susceptible organs are the arteries, brain, kidneys, and heart. The damage mechanisms include oxidative stress and renin-angiotensin system (RAS) overactivity. Therefore, our aim was to study whether clofibrate-induced peroxisome proliferator-activated receptor-alpha (PPAR-α) stimulation is able to prevent alterations in cardiac functioning derived from RAS overstimulation in the left ventricle of rats with hypertension secondary to aortic coarctation and to improve antioxidant defenses. Male Wistar rats were assigned to Control (Sham)- or aortic coarctation-surgery and further divided to receive (1 or 21 days) vehicle, clofibrate (100mg/kg), captopril (20mg/kg), or clofibrate+captopril. The left ventricle was obtained to measure: angiotensin II and -(1-7), AT1 and AT2 receptors, angiotensin converting enzyme (ACE)-1 and -2, and MAS receptor; the activity and expression of superoxide dismutase, catalase, endothelial nitric oxide synthase, the production of reactive oxygen species (ROS) and peroxidated lipids; as well as ex vivo cardiac functioning. Clofibrate decreased angiotensin II, AT1 receptor and ACE expression, and raised angiotensin-(1-7), AT2 receptor, ACE-2 expression, superoxide dismutase and endothelial nitric oxide synthase participation. These effects promoted lower coronary vascular resistance and improved mechanical work compared to aortic coarctated vehicle-treated rats. Clofibrate-induced PPAR-α stimulation changes the angiotensin II receptor profile, favors the ACE2/angiotensin-(1-7)/AT2 receptor axis decreasing the vasoconstrictor environment, activates the antioxidant defense, and facilitates endothelial nitric oxide synthase activity favoring vasodilation. This may represent a protection for the stressed heart.Keywords
Funding Information
- Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico (222720)
This publication has 29 references indexed in Scilit:
- Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance StudyJournal of the American Heart Association, 2015
- A mitochondrial superoxide theory for oxidative stress diseases and agingJournal of Clinical Biochemistry and Nutrition, 2015
- AT2 Receptor and Tissue Injury: Therapeutic ImplicationsCurrent Hypertension Reports, 2014
- Immune mechanisms in hypertension and vascular injuryClinical Science, 2013
- Angiotensin II and the vascular phenotype in hypertensionExpert Reviews in Molecular Medicine, 2011
- Point: Chronic Activation of the Sympathetic Nervous System is the Dominant Contributor to Systemic HypertensionJournal of Applied Physiology, 2010
- Peroxisome proliferator-activated receptor α activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the ratJournal Of Hypertension, 2008
- Nitrosative stress and pharmacological modulation of heart failureTrends in Pharmacological Sciences, 2005
- Cardiac oxidative stress in acute and chronic isoproterenol-infused ratsCardiovascular Research, 2005
- Peroxisome proliferator‐activated receptors in the cardiovascular systemBritish Journal of Pharmacology, 2000